The role of the marketer is changing
PharmaTimes talks to Sabina Syed, managing director, Visions4Health and co-chair of the Marketer of the Year steering group about the importance of the competition against an ever changing landscape.
Read More
Search Results for: Mark Fish
Pharma charged with ‘unscrupulous’ marketing practices
A damning report on the pharmaceutical industries marketing practices, issued by lobby group Consumers International, has called for governments around the world to tighten controls on drugmakers.
Read More
Building the digital lab of the future
The modern digital lab will truly transform how biopharmaceutical products are created and brought to market
Novartis delves deeper into immunotherapy with CoStim buy
Novartis is evidently angling for a larger slice of the potentially lucrative cancer immunotherapy market having snapped up Cambridge, Massachusetts-based biotech CoStim for an undisclosed sum.
Read More
Biomarkers and a battle of the bases
Why RNA is the future of diagnostics
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
